Choksi Labs FY26 net profit rises 29% to ₹196.43 lakh

Choksi Laboratories Limited reported a 29% increase in net profit to ₹196.43 lakh for the financial year ended March 31, 2026, compared to ₹152.33 lakh in the previous year. The company's revenue from operations for FY26 stood at ₹4600.59 lakh, up from ₹4178.23 lakh in FY25. The Board of Directors approved the audited financial results during a meeting held on May 25, 2026, and the results were published in newspapers on May 26, 2026, in compliance with Regulation 47 of the SEBI (LODR) Regulations, 2015.

Financial Performance

For the quarter ended March 31, 2026, the company recorded a net profit of ₹102.68 lakh, compared to ₹92.13 lakh in the corresponding quarter of the previous year. Total revenue for the year ended March 31, 2026, reached ₹4621.93 lakh. Profit before tax for the year was ₹319.46 lakh, higher than the ₹215.33 lakh recorded in the preceding financial year. The basic and diluted earnings per share (EPS) for the year were ₹2.82, compared to ₹2.19 in the previous year.

Operational Details

Choksi Laboratories identified "Analysis and Testing" as its single operating segment. The statutory auditors, M/s Prateek Jain & Co., Chartered Accountants, issued an unmodified opinion on the financial results. During the quarter, the company sold an office flat, resulting in a gain of ₹75.30 lakh, which was disclosed as an exceptional item.

Financial Metric	FY26 (₹ in Lakhs)	FY25 (₹ in Lakhs)
Revenue from Operations	4600.59	4178.23
Total Revenue	4621.93	4184.94
Total Expenses	4377.77	3969.61
Net Profit	196.43	152.33
Basic EPS (₹)	2.82	2.19

Assets and Cash Flow

As of March 31, 2026, the company's total assets were valued at ₹7192.08 lakh, an increase from ₹6533.21 lakh in the previous year. Total equity stood at ₹2557.54 lakh, while total liabilities were recorded at ₹4634.54 lakh. Cash and cash equivalents at the end of the financial year stood at ₹20.67 lakh. Net cash generated from operating activities was ₹786.48 lakh, while investing activities resulted in a net cash outflow of ₹707.46 lakh.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-3.05%	-6.14%	+18.31%	+0.68%	-12.71%	+757.55%

Choksi Laboratories Limited has announced the appointment of Mrs. Stela Choksi as the Chief Financial Officer (CFO) of the company. The board of directors approved the appointment during a meeting held on May 18, 2026, based on the recommendation of the Audit and Nomination & Remuneration Committee.

Mrs. Stela Choksi is a promoter member of the company and brings diversified experience in finance and administration. The company stated that she has successfully built a team of experts and maintains keen observation of daily operations through her visionary management skills.

Authorized Personnel for Disclosures

Following the appointment, the board has authorized Mrs. Stela Choksi to determine the materiality of events or information and make disclosures to the Stock Exchanges. She joins other Key Managerial Personnel who are jointly authorized under Regulation 30(5) of the SEBI Listing Regulations.

S. No.	Name and Designation	Contact Details
1	Mr. Sunil Choksi – Managing Director	Tel: 0731-3501112 Email: compliance_officer@choksilab.in
2	Mrs. Stela Choksi – Whole Time Director and CFO
3	Mr. Prakhar Dubey – Company Secretary

Appointee Profile

Mrs. Stela Choksi holds DIN 0155043 and was born on August 5, 1958. Her appointment took effect on May 18, 2026. The disclosure confirmed her relationships with other directors, identifying her as the relative of Mr. Sunil Choksi (Managing Director and husband), Ms. Himika Choksi (Whole Time Director and daughter), and Mr. Vyangesh Choksi (Whole Time Director and son).